Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies

BACKGROUND: Glioblastoma (GBM) is the most malignant among gliomas with an inevitable lethal outcome. The elucidation of the physiology and regulation of this tumor is mandatory to unravel novel target and effective therapeutics. Emerging concepts show that the minor subset of glioblastoma stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Visioli, Alberto, Trivieri, Nadia, Mencarelli, Gandino, Giani, Fabrizio, Copetti, Massimiliano, Palumbo, Orazio, Pracella, Riccardo, Cariglia, Maria Grazia, Barile, Chiara, Mischitelli, Luigi, Soriano, Amata Amy, Palumbo, Pietro, Legnani, Federico, DiMeco, Francesco, Gorgoglione, Leonardo, Pesole, Graziano, Vescovi, Angelo L., Binda, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512479/
https://www.ncbi.nlm.nih.gov/pubmed/37735434
http://dx.doi.org/10.1186/s13046-023-02811-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512479/
https://www.ncbi.nlm.nih.gov/pubmed/37735434
http://dx.doi.org/10.1186/s13046-023-02811-0

Ejemplares similares